Teresa Brevini - Publications

Successful AAV8 gene therapy on hepatic ex situ machine perfusion for mitochondrial neurogastrointestinal encephalomyopathy.

Journal: Journal of hepatology

Published: February 23, 2025

Modelling the potential use of pre-exposure prophylaxis to reduce nosocomial SARS-CoV-2 transmission.

Journal: PLoS computational biology

Published: December 13, 2024

Time will tell: Employing long-term normothermic machine perfusion to gain new insight into bile duct regeneration.

Journal: American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons

Published: August 06, 2024

Single-Cell Transcriptomic Profiling of Cholangiocyte Organoids Derived from Bile Ducts of Primary Sclerosing Cholangitis Patients.

Journal: Digestive diseases and sciences

Published: April 03, 2024

Ursodeoxycholic acid is associated with a reduction in SARS-CoV-2 infection and reduced severity of COVID-19 in patients with cirrhosis.

Journal: Journal of internal medicine

Published: April 05, 2023

Organoids and regenerative hepatology.

Journal: Hepatology (Baltimore, Md.)

Published: February 15, 2022

Altered TMPRSS2 usage by SARS-CoV-2 Omicron impacts infectivity and fusogenicity.

Journal: Nature

Published: December 21, 2021

FXR inhibition may protect from SARS-CoV-2 infection by reducing ACE2.

Journal: Nature

Published: May 03, 2021

Cardiovascular ACE2 receptor expression in patients undergoing heart transplantation.

Journal: ESC heart failure

Published: March 06, 2021

Tissue engineering of the biliary tract and modelling of cholestatic disorders.

Journal: Journal of hepatology

Published: January 27, 2020

Cholangiocyte organoids can repair bile ducts after transplantation in the human liver.

Journal: Science (New York, N.Y.)

Published: November 10, 2019

Use of Biliary Organoids in Cholestasis Research.

Journal: Methods in molecular biology (Clifton, N.J.)

Published: April 25, 2019